Flexion Therapeutics Inc
Officers & Directors
1. Michael Clayman e Co-Founder and Executive Chairman
Dr. Michael Clayman is a co-founder and executive chairman of Flexion Therapeutics Inc. Before that, he served as the CEO and President of the company. Dr. Clayman is a rheumatologist with more than 30 years of experience in the pharmaceutical industry. He is also a co-founder of Sera Prognostics and a board member of numerous pharmaceutical companies.
2. Michael W. Berelowitz e Chief Executive Officer
Mr. Michael W. Berelowitz is the current CEO at Flexion Therapeutics. He has been with the company since 2017, serving as the Chief Commercial Officer and later as President before taking on the CEO role. He has more than 20 years of experience in the pharmaceutical industry, particularly in roles related to commercialization and marketing.
3. David Arkowitz e Chief Financial Officer
Mr. David Arkowitz is a Chief Financial Officer at Flexion Therapeutics Inc. He joined the company in 2020 with more than 30 years of experience in the biopharmaceutical industry. Previously, he was the CFO of Viamet Pharmaceuticals, Inc., a biopharmaceutical company.
4. Scott Kelley e Executive Vice President and Chief Medical Officer
Dr. Scott Kelley is an Executive Vice President and Chief Medical Officer at Flexion Therapeutics Inc. He has more than 20 years of experience in clinical development and medical affairs. Prior to joining Flexion Therapeutics, he held senior leadership positions at several biopharmaceutical companies, including Biogen Idec and Vertex Pharmaceuticals.
5. Neil Bodick e Executive Vice President and Chief Scientific Officer
Dr. Neil Bodick is an Executive Vice President and Chief Scientific Officer at Flexion Therapeutics Inc. He has extensive experience in clinical research and drug development. Prior to joining Flexion Therapeutics, he served as the Vice President of Immunology and Inflammation Discovery at Pfizer, Inc.
6. Linda Hogan e Director
Ms. Linda Hogan is a member of the Board of Directors at Flexion Therapeutics Inc. She has more than 25 years of experience in the biopharmaceutical industry, including senior executive roles at Amgen, Inc. and Plexxikon, Inc. She currently serves as Chief Executive Officer at Biodel, Inc.
Mark Stejbach e Director
Mr. Mark Stejbach is a member of the Board of Directors at Flexion Therapeutics Inc. He has more than 30 years of healthcare industry experience, including executive roles at Takeda Pharmaceuticals and Eli Lilly and Company. Currently, he serves as an advisor to multiple biotechnology companies.
Flexion Therapeutics Inc currently has 215 employees.
|
